| 12492171 |
Heterocyclic inhibitors of MCT4 |
Kenneth Mark Parnell, Donna L. Romero |
2025-12-09 |
|
| 12201639 |
Aqueous oral pharmaceutical suspension compositions |
Jesse DAMSKER |
2025-01-21 |
|
| 12187682 |
MCT4 inhibitors for treating disease |
Kenneth Mark Parnell |
2025-01-07 |
|
| 11833159 |
Non-hormonal steroid modulators of NF-kB for treatment of disease |
Eric Hoffman, Kanneboyina Nagaraju |
2023-12-05 |
|
| 11771684 |
Inhibitors of dihydroceramide desaturase for treating disease |
Donna L. Romero, Jeremy Blitzer |
2023-10-03 |
|
| 11773068 |
KDM1A inhibitors for the treatment of disease |
Hugh Y. Rienhoff, Jr., Michael Clare, Cassandra Celatka, Amy E. Tapper |
2023-10-03 |
|
| 11724989 |
MCT4 inhibitors for treating disease |
Kenneth Mark Parnell |
2023-08-15 |
|
| 11690853 |
Non-hormonal steroid modulators of NF-κβ for treatment of disease |
Eric Hoffman, Kanneboyina Nagaraju, Jesse DAMSKER |
2023-07-04 |
|
| 11661409 |
Acid addition salts, compositions, and methods of treating |
Harris A. Gelbard, Jesse DAMSKER, Arthur Glenn Romero |
2023-05-30 |
|
| 11655226 |
KDM1A inhibitors for the treatment of disease |
Hugh Y. Rienhoff, Jr., Michael Clare |
2023-05-23 |
|
| 11479541 |
Acid addition salts, compositions, and methods of treating thereof |
Harris A. Gelbard, Jesse DAMSKER, Arthur Glenn Romero |
2022-10-25 |
|
| 11471471 |
Aqueous oral pharmaceutical suspension compositions |
Jesse DAMSKER |
2022-10-18 |
|
| 11459307 |
Heterocyclic compounds for the inhibition of PASK |
Donna L. Romero, John McKearn, Michael Clare |
2022-10-04 |
|
| 11390590 |
Methods and processes for the preparation of KDM1A inhibitors |
Amy E. Tapper, Cassandra Celatka, Arthur Glenn Romero, Toni Chancellor, Jian-Xie Chen +6 more |
2022-07-19 |
$11,531,000 |
| 11382922 |
Aqueous oral pharmaceutical suspension compositions |
Jesse DAMSKER |
2022-07-12 |
|
| 11292767 |
Heterocyclic inhibitors of MCT4 |
Kenneth Mark Parnell, Donna L. Romero |
2022-04-05 |
|
| 11230534 |
KDM1A inhibitors for the treatment of disease |
Hugh Y. Rienhoff, Jr., Michael Clare, Cassandra Celatka, Amy E. Tapper |
2022-01-25 |
$13,019,000 |
| 11191765 |
Heterocyclic compounds for the inhibition of PASK |
Robert C. Kelly, Donna L. Romero |
2021-12-07 |
|
| 11155522 |
MCT4 inhibitors for treating disease |
Kenneth Mark Parnell |
2021-10-26 |
|
| 11135207 |
Inhibitors of dihydroceramide desaturase for treating disease |
Donna L. Romero, Jeremy Blitzer |
2021-10-05 |
|
| 10953012 |
Heterocyclic compounds for the inhibition of pask |
Robert C. Kelly, Donna L. Romero |
2021-03-23 |
|
| 10882835 |
KDM1A inhibitors for the treatment of disease |
Hugh Y. Rienhoff, Jr., Michael Clare |
2021-01-05 |
|
| 10857161 |
Non-hormonal steroid modulators of NF-kB for treatment of disease |
Eric Hoffman, Kanneboyina Nagaraju |
2020-12-08 |
|
| 10799514 |
Non-hormonal steroid modulators of NF-kappa beta for treatment of disease |
Eric Hoffman, Kanneboyina Nagaraju, Jesse DAMSKER |
2020-10-13 |
|
| 10781185 |
Heterocyclic compounds for the inhibition of PASK |
Donna L. Romero, John McKearn, Michael Clare |
2020-09-22 |
|